12 Monthly Surveillance Audit by DNV

13th January 2011, Maverick Biosciences Limited and Maverick Biosciences (NZ) Limited today received a surveillance audit by Det Norske Veritas.

There were no ‘Non Conformities’ found in either minor or major categories, 1 observation was noted. The Quality Management system was found to be in satisfactory order and continued to meet the specifications of the certifying body.

The organizations Quality Manager is currently reviewing the needs of ISO13485:2003. for consideration as we continue to invest in enhancing Mavericks capabilities to meet and exceed clients needs.

PRESS RELEASES

Glutaraldehyde processing work commences in Dubbo, Australia

Jun 10, 2009

Maverick has been working with a number of start-up clients to resolve their need for "backroom" processing activities to be undertaken as an outsourced function so as to reduce their infrastructural investment and provide them more time and focus on key objectives....

New Zealand production of device tissues commenced on an ongoing basis

May 1, 2009

After completion of a number of validation shipments Maverick New Zealand has commenced ongoing production of device tissues this month against a clients need for a dual sourced supply chain to meet regulatory requirements, and board directives to manage disease risk....

Maverick to produce sized porcine leaflets

Feb 1, 2009

Maverick has this week, drafted a project plan for the production and selection of sized porcine leaflets, for fixation in Australia, prior to export. Expanding upon its success in the bovine and equine tissues area, Maverick has built a project plan for a customised...

PRODUCT CATEGORIES